Kevin Clancy Email & Phone Number

Carlsbad, Ca, Us

I'm establishing a Genomics unit in a new laboratory space in CHIPSA Hospital, Tijuana. We will be using NGS technologies to help our Oncology and Regenerative medicine patients.

Kevin founded BioCoder Consulting, in order to solve significant bioinformatics challenges for companies in the pharmaceutical and industrial biotech sectors. Kevin brings over two decades of industrial experience leading bioinformatics teams, and developing and commercializing genomics software. Kevin has served on the scientific advisory committee of the Synthetic Biology Open Language since 2015. He has more than 25 peer reviewed publications and is an inventor on more than 4 patents.BioCoder provides services in1. Data analytics, including recommendation of approach, analysis and training in bioinformatics tools, algorithm development, NGS analytics and machine learning.2. Software and Bioinformatics engineering, including development of algorithms, pipeline development LIMS development. I also provide expertise in desktop, enterprise and Cloud computing, including deployment of solutions and training.3. Business analysis, including market and product analytics, development of business and functional requirements and, implementation of processes and metrics to align projects with company goals.

Salt Lake City, Utah, Us

Built and led a small initiative to enable Myriad to participate inHealth Informatics. This included:1. Defining the scope of Health Informatics and how Myriad would bring value to it's customers2. Setting up external sets of data termed Registries to share data sets and to encourage collaborations3. Working with external customers to define their data needs and deliver on these4. Set up a small agile team to develop, prototype and fail fast over a variety of solutions.

San Francisco, Ca, Us

Develop solutions for FAIR data practices and providing Data Science and Analytics capabilities for RUO and IVD groups developing cutting edge WGS & WES NGS tools for RUO, IVD, medical devices and lab developed tests for Cancer diagnostics. Directly managed data analysts, scientists, statisticians, developers, LIMS administrators, program and project managers.• Developed custom data collection practices for RUO, IVD, LDT and CDx studies using off the shelf and custom solutions for DNA, RNA and circulating free DNA targeting therapeutic cancer biomarkers. • Developed and implemented LIMS, AWS and software solutions compliant with validated Product & Non-Product softwares to capture data from internal development, teams, external CROs and Pharma partners. • Provided data analytics to guide and improve lab work using a range of solutions from data analytics through to dashboards.• Developed and maintained quality controlled software development life cycle in compliance with governmental regualtions and partner specific needs• Managed data from intenal sources, partnered clinical research organizations, and as RUO and Companion diagnostics with pharma partners.

La Jolla, Ca, Us

I provided strategic director level leadership across SGI by:1. Providing direction in use of bioinformatics across the organization2. Integration of teams to deliver technologies and analyses across the organization3. Developing and implementing infrastructure and solutions for for Illumina, PacBio and Oxford Nanopore next gen library prep, sequencing and analysis using R and R-Studio4. Performing custom bioinformatics services for external customers5. Business planning and employee career management, resource and CAR planning and purchase, corporate matrix management6. Reported into C-level management, business leaders, and senior scientific staff to coordinate activities of the group with corporate goals and objectives6. Integrating group goals with Legal, Regulatory and Business needs

Waltham, Ma, Us

Senior Scientist delivering bioinformatics solutions for Synthetic & Systems Biology- Lead scientist for the Vector NTI program from 2000 - 2017. Developed, maintained and managed the software, it's scientific direction and the introduction of new tools and technologies. Provided scientific leadership in the business development of the program.- Provide Next generation sequence infrastructure design, algorithm development and data analysis for de novo and reference genome assemblies, transcriptome analysis and annotation of genes, proteins and reactions in a range of prokaryotic and eukaryotic orgnaisms;- Developed and use software tools and infrastructure to support metabolic flux analysis and cellular network analyses- Develop commercial Software tools to support analysis and use of Synthetic Biology practices to experimental design- Developed and launched of a new platform for the Vector NTI product line- Sponsored research to develop novel synthetic biology parts development- Supported new product launches through provision of tools ranging from in-house prototypes through to scientific design tools supporting commercial sales- Manage and coordinate teams of people over four time zones from Germany through to Singapore- Work with the Synthetic Biology Open language community as Leadership Committee member.- Reported and coordinated goals, activities, budget and P&L responsibilities with senior management, including VP of Research and Business for the unit, the CSO office and CBO offices for ThermoFisher's Biologics Business Unit

Waltham, Ma, Us

Senior Scientist delivering bioinformatics solutions for Synthetic & Systems Biology- Lead scientist for the Vector NTI program. Developed, maintained and managed the software, it's scientific direction and the introduction of new tools and technologies. Provided scientific leadership in the business development of the program.- Provide Next generation sequence infrastructure design, algorithm development and data analysis for de novo and reference genome assemblies, transcriptome analysis and annotation of genes, proteins and reactions in a range of prokaryotic and eukaryotic orgnaisms;- Developed and use software tools and infrastructure to support metabolic flux analysis and cellular network analyses- Develop commercial Software tools to support analysis and use of Synthetic Biology practices to experimental design- Developed and launched of a new platform for the Vector NTI product line- Sponsored research to develop novel synthetic biology parts development- Supported new product launches through provision of tools ranging from in-house prototypes through to scientific design tools supporting commercial sales- Manage and coordinate teams of people over four time zones from Germany through to Singapore- Work with the Synthetic Biology Open language community as an Editor.

I managed teams of scientsts, developers and testers that provided bioinformatics skills and experiences to a variety of projects, including:Senior scientist for support and development of commercial desktop and enterprise server software product lines, notably the GenoMax, LabShare and Vector NTI product lines;We delivered Custom algorithm development for customer driven projectsNGS analysis and computaitonal support for Illumina & SOLiD platforms for transcriptome, SAGE, epigenetic and CHiP applications for kit development by the invitrogen NGS group;Software and algorithmic design for FDA and Regulatory Compliant Systems for Transplantation Diagnostics;Software and tools for drug screening and pathogen studies in lab animals for the BioReliance groupTools for pathogen analysis in screening devices for the BioDefense groupBiological Software design and implementation for many types of Omics projectsOntology development and Advanced Text Mining for more efficient ways to match biological questions to supporting protocols and reagentsPerforming Novel and Standardized Mathematical Analyses and Data Visualization

I managed a group of bioinformaticists, developers, QA testers, technical support and training specialists and documentation personnel. We delivered professional services for custom and off the shelf products, installed, trained and supported solutions. We enabled company growth eventually resulting in InforMax being able to IPO in 2002.

I conducted research on:autosomal dominant early onset alzheimer;s disease;autosomal dominant inclusion body myositis, and;mapped genes to chromosomes through FISH technologies

I conducted original research on:autosomal dominant cataract and retinitis pigmentosa;autosomal dominant inclusion body myositis;performed linkage analysis on genotyping results, and;annotated the first drafts of human Chromosome 21 for the Chromosome 21 consortium.I helped direct and manage the introduction of genotying tools and methods into these groups. I performed systems administration work on the local computer network, setting up the infrastructure and pipeline to annotate chrmoosomal segments, identfy known and novel genes and publish these onto a web site..

I isolated and characterized partial ligand gated ion channel receptor sequences in C. elegans and canine parasitic worms.

I developed a panel of 2200 cDNAs showing differential expression throughout the rat CNS to support a grant from the Motor Neuron Disease Association.I supported the use and operation of a BSL2 laboratory.I used skills and knowledge of molecular biology techniques to support experiments throughout the department.I developed computer skills for custom data analysis with Perl and initial versions of BioPerl.

Phd, Molecular Neurobiology

Bsc(Hons) Biochemistry, Biochemistry